Literature DB >> 12460916

Functional genomic comparison of lineage-related human bladder cancer cell lines with differing tumorigenic and metastatic potentials by spectral karyotyping, comparative genomic hybridization, and a novel method of positional expression profiling.

Michael A Harding1, Karen C Arden, James W Gildea, John J Gildea, Elizabeth J Perlman, Carrie Viars, Dan Theodorescu.   

Abstract

We have recently characterized T24T, an invasive and metastatic variant of the T24 human bladder cell line, resulting in a model for bladder cancer progression. To gain additional insight into the repertoire of genetic changes that may be responsible for the invasive and metastatic phenotype, we used spectral karyotyping (SKY) in combination with comparative genomic hybridization (CGH) in these cells. To assess the functional significance of the genetic differences found between the two cell lines, we have developed a positional expression profiling (PEP) method for comparing gene expression data obtained from oligonucleotide microarrays based upon chromosomal position. Using SKY and CGH, we were able to define the genetic changes in the cell lines, and in addition, resolve the identity of all marker chromosomes from our initial karyotyping and G-band analysis. PEP analysis revealed important similarities and differences when compared with the cytogenetic data, allowing insights of how genomic structural changes affect gene expression on a regional scale. The shape of the expression profiles for chromosomes 8, 12, and X correlated well with the numerical imbalances revealed by CGH and SKY, whereas regions like 10q, gained in T24T compared with T24, was not associated with changes in gene expression. Furthermore, we have shown that 12p, a region of agreement between CGH and PEP harbors RhoGDI2, a candidate gene, the expression of which inversely correlates with bladder tumor progression, demonstrating the usefulness of this multimodal approach in identifying promising genetic changes that may be responsible for the invasive phenotype.

Entities:  

Mesh:

Year:  2002        PMID: 12460916

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  17 in total

Review 1.  Metastasis-suppressor genes in clinical practice: lost in translation?

Authors:  Alexander N Shoushtari; Russell Z Szmulewitz; Carrie W Rinker-Schaeffer
Journal:  Nat Rev Clin Oncol       Date:  2011-04-26       Impact factor: 66.675

2.  Profiling bladder cancer organ site-specific metastasis identifies LAMC2 as a novel biomarker of hematogenous dissemination.

Authors:  Steven Christopher Smith; Brian Nicholson; Matthew Nitz; Henry F Frierson; Mark Smolkin; Garret Hampton; Wael El-Rifai; Dan Theodorescu
Journal:  Am J Pathol       Date:  2009-01-15       Impact factor: 4.307

3.  Comparison of global versus epidermal growth factor receptor pathway profiling for prediction of lapatinib sensitivity in bladder cancer.

Authors:  Dmytro M Havaleshko; Steven Christopher Smith; HyungJun Cho; Sooyoung Cheon; Charles R Owens; Jae K Lee; Lance A Liotta; Virginia Espina; Julia D Wulfkuhle; Emanuel F Petricoin; Dan Theodorescu
Journal:  Neoplasia       Date:  2009-11       Impact factor: 5.715

4.  Combining differential expression, chromosomal and pathway analyses for the molecular characterization of renal cell carcinoma.

Authors:  Kyle A Furge; Karl Dykema; David Petillo; Michael Westphal; Zhongfa Zhang; Eric J Kort; Bin Tean Teh
Journal:  Can Urol Assoc J       Date:  2007-06       Impact factor: 1.862

5.  Chromosome instability, chromosome transcriptome, and clonal evolution of tumor cell populations.

Authors:  ChongFeng Gao; Kyle Furge; Julie Koeman; Karl Dykema; Yanli Su; Mary Lou Cutler; Adam Werts; Pete Haak; George F Vande Woude
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-15       Impact factor: 11.205

Review 6.  The Ral GTPase pathway in metastatic bladder cancer: key mediator and therapeutic target.

Authors:  Steven Christopher Smith; Dan Theodorescu
Journal:  Urol Oncol       Date:  2009 Jan-Feb       Impact factor: 3.498

Review 7.  Learning therapeutic lessons from metastasis suppressor proteins.

Authors:  Steven Christopher Smith; Dan Theodorescu
Journal:  Nat Rev Cancer       Date:  2009-02-26       Impact factor: 60.716

8.  Somatic pairing of chromosome 19 in renal oncocytoma is associated with deregulated EGLN2-mediated [corrected] oxygen-sensing response.

Authors:  Julie M Koeman; Ryan C Russell; Min-Han Tan; David Petillo; Michael Westphal; Katherine Koelzer; Julie L Metcalf; Zhongfa Zhang; Daisuke Matsuda; Karl J Dykema; Heather L Houseman; Eric J Kort; Laura L Furge; Richard J Kahnoski; Stéphane Richard; Annick Vieillefond; Pamela J Swiatek; Bin Tean Teh; Michael Ohh; Kyle A Furge
Journal:  PLoS Genet       Date:  2008-09-05       Impact factor: 5.917

9.  A quantitative proteomic analysis uncovers the relevance of CUL3 in bladder cancer aggressiveness.

Authors:  Laura Grau; Jose L Luque-Garcia; Pilar González-Peramato; Dan Theodorescu; Joan Palou; Jesus M Fernandez-Gomez; Marta Sánchez-Carbayo
Journal:  PLoS One       Date:  2013-01-08       Impact factor: 3.240

10.  Placenta-specific novel splice variants of Rho GDP dissociation inhibitor β are highly expressed in cancerous cells.

Authors:  Keiichi Hatakeyama; Yorikane Fukuda; Keiichi Ohshima; Masanori Terashima; Ken Yamaguchi; Tohru Mochizuki
Journal:  BMC Res Notes       Date:  2012-12-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.